These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9368579)

  • 1. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice.
    Choudhri TF; Hoh BL; Solomon RA; Connolly ES; Pinsky DJ
    Stroke; 1997 Nov; 28(11):2296-302. PubMed ID: 9368579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
    Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
    Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL
    Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endogenous versus exogenous tPA on edema formation in murine ICH.
    Thiex R; Mayfrank L; Rohde V; Gilsbach JM; Tsirka SA
    Exp Neurol; 2004 Sep; 189(1):25-32. PubMed ID: 15296833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
    Reuter B; Grudzenski S; Chatzikonstantinou E; Meairs S; Ebert A; Heiler P; Schad LR; Staufenbiel M; Hennerici MG; Fatar M
    Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased brain edema after collagenase-induced intracerebral hemorrhage in mice lacking the inducible nitric oxide synthase gene. Laboratory investigation.
    Kim DW; Im SH; Kim JY; Kim DE; Oh GT; Jeong SW
    J Neurosurg; 2009 Nov; 111(5):995-1000. PubMed ID: 19374494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke?
    Kimura K; Sakai K; Iguchi Y; Shibazaki K; Sakamoto Y
    Eur Neurol; 2011; 65(5):245-9. PubMed ID: 21464569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
    Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
    Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):964-71. PubMed ID: 11487732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhage in the Interventional Management of Stroke study.
    IMS Study Investigators
    Stroke; 2006 Mar; 37(3):847-51. PubMed ID: 16439694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase.
    Zhu W; Gao Y; Chang CF; Wan JR; Zhu SS; Wang J
    PLoS One; 2014; 9(5):e97423. PubMed ID: 24831292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat.
    Liddle L; Reinders R; South S; Blacker D; Knuckey N; Colbourne F; Meloni B
    PLoS One; 2019; 14(11):e0224870. PubMed ID: 31697775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.
    Zhou W; Zorn M; Nawroth P; Bütehorn U; Perzborn E; Heitmeier S; Veltkamp R
    Stroke; 2013 Mar; 44(3):771-8. PubMed ID: 23339956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats.
    Elger B; Seega J; Brendel R
    Stroke; 1994 Sep; 25(9):1836-41. PubMed ID: 8073466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.
    Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M
    Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental model of warfarin-associated intracerebral hemorrhage.
    Foerch C; Arai K; Jin G; Park KP; Pallast S; van Leyen K; Lo EH
    Stroke; 2008 Dec; 39(12):3397-404. PubMed ID: 18772448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonist.
    Mihara K; Aoki T; Moriguchi A; Maeda M; Furuichi Y; Matsuoka N; Mutoh S
    J Neurotrauma; 2005 Nov; 22(11):1362-73. PubMed ID: 16305324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.